Alvin Wong

5.6k citations
72 papers · 2.0k indexed · h-index 25
Topics
Multiple Myeloma Research and Treatments (19 papers)Protein Degradation and Inhibitors (17 papers)Cancer Treatment and Pharmacology (9 papers)
Partner nations
United StatesCanadaSpain

In The Last Decade

Alvin Wong

68 papers receiving 2.0k citations

Peers

Alvin Wong
Comparison fields: 5 of 98
  • Molecular Biology 1.0k
  • Oncology 726
  • Hematology 693
  • Surgery 313
  • Pulmonary and Respiratory Medicine 303
Replace Uri Rozovski with:
Uri Rozovski Israel
Josef Thaler Austria
Francis J. Giles United States
Daniel Chubb Australia
Ta‐Chih Liu Taiwan
Michael Medinger Switzerland
Ali Amirkhosravi United States
Stéphane Loyau France
Sheeba K. Thomas United States
Claudia Fleissner Germany
Alvin Wong relative to Uri Rozovski Israel Uri Rozovski's profile →
Citations per field
00.5×1.5×2.5×
Uri Rozovski · 1×
Citations per year

Countries citing papers authored by Alvin Wong

Since Specialization
Citations

This map shows the geographic impact of Alvin Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alvin Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alvin Wong more than expected).

Fields of papers citing papers by Alvin Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alvin Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alvin Wong. The network helps show where Alvin Wong may publish in the future.

Co-authorship network of co-authors of Alvin Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Alvin Wong. A scholar is included among the top collaborators of Alvin Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alvin Wong. Alvin Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 2
4 1
5 86
6 2
7 27
8 18
9 2
10 119
11 81
12 123
13 15
14 22
15 5
16 98
17 41
18
The targeted cytotoxic prodrug, AQ4N, persists in the spleen, large intestine, and subcutaneous tumors
0
19 6
20 61

About Alvin Wong

Alvin Wong is a scholar working on Hematology, Genetics and Oncology, having authored 72 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (17 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Hematology (693 citations), Oncology (726 citations) and Genetics (201 citations). Alvin Wong has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Lori Kunkel, David S. Siegel, Melissa Alsina, Robert Z. Orlowski, Rubén Niesvizky, Ashraf Badros, Ravi Vij, June K. Wu, Leanne McCulloch and Sundar Jagannath. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026